Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Clinical Colorectal Cancer
Published October 2, 2026
Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab as Third-Lin...
October 23, 2026
Medspoke
Medspoke
British Journal of Cancer
Published October 21, 2026
00:00
--:--
Inhibition of ACSS2 enhances cabozantinib sensitivity by blocking TFEB-induced autophagic flux in...
October 23, 2026
Share
Inhibition of ACSS2 enhances cabozantinib sensitivity by blocking TFEB-induced autophagic flux in hepatocellular carcinoma.
https://www.medspoke.co/channel_journal?id=785&tap_id=16097
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Diabetes
Published October 21, 2026
Novel Protein Biomarkers to Monitor Kidney Function Decline and Treatment Response in Individuals...
October 23, 2026
Why are you reporting this TALK?
